Metabolic engineering and directed evolution for the production of pharmaceuticals
- 1 April 2000
- journal article
- review article
- Published by Elsevier in Current Opinion in Biotechnology
- Vol. 11 (2), 209-214
- https://doi.org/10.1016/s0958-1669(00)00081-1
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- A chain initiation factor common to both modular and aromatic polyketide synthasesNature, 1999
- The specificity-conferring code of adenylation domains in nonribosomal peptide synthetasesChemistry & Biology, 1999
- Tolerance and Specificity of Polyketide SynthasesAnnual Review of Biochemistry, 1999
- Dissecting and Exploiting Intermodular Communication in Polyketide SynthasesScience, 1999
- Evaluating precursor-directed biosynthesis towards novel erythromycins through in vitro studies on a bimodular polyketide synthaseChemistry & Biology, 1998
- Synthesis and Incorporation of an N-Acetylcysteamine Analogue of Methylmalonyl-CoA by a Modular Polyketide SynthaseJournal of the American Chemical Society, 1998
- Ethyl-substituted erythromycin derivatives produced by directed metabolic engineeringProceedings of the National Academy of Sciences, 1998
- Spontaneous Priming of a Downstream Module in 6-Deoxyerythronolide B Synthase Leads to Polyketide BiosynthesisBiochemistry, 1998
- Primer Unit Specificity in Rifamycin Biosynthesis Principally Resides in the Later Stages of the Biosynthetic PathwayJournal of the American Chemical Society, 1998
- Novel Erythromycins from a Recombinant Saccharopolyspora erythraea Strain NRRL 2338 pIG1. I. Fermentation, Isolation and Biological Activity.The Journal of Antibiotics, 1998